Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

Annals of General Psychiatry

Volumn 9, Issue , 2010, Pages

  Yang, Huaiyu ^a   Sinicropi Yao, Lara ^a   Chuzi, Sarah ^a   Youn, Soo J ^a   Clain, Alisabet ^a   Baer, Lee ^a   Chen, Ying ^b   McGrath, Patrick J ^b   Fava, Maurizio ^a   Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; HYPERSOMNIA; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; SLEEP DISORDER; SURVIVAL; TREATMENT DURATION;

EID: 77949344510     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-9-10     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC, USA: American Psychiatric Association, 4, American Psychiatric Association.
2. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). 1995, New York, NY, USA: Biometrics Research Department, New York State Psychiatric Institute.
3. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M,STAR*D Study Team Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28-40. 10.1176/appi.ajp.163.1.28, 16390886, STAR*D Study Team.
4. Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 2008, 69:246-258. 10.4088/JCP.v69n0211, 18363453.
5. Fava GA, Grandi S, Canestrari R, Molnar G. Prodromal symptoms in primary major depressive disorder. J Affect Disord 1990, 19(Suppl 2):149-152. 10.1016/0165-0327(90)90020-9, 2142701.
6. Perlis ML, Smith LJ, Lyness JM, Matteson SR, Pigeon WR, Jungquist CR, Tu X. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006, 4(Suppl 2):104-113. 10.1207/s15402010bsm0402_3, 16579719.
7. Roberts RE, Shema SJ, Kaplan GA, Strawbridge WJ. Sleep complaints and depression in an aging cohort: a prospective perspective. Am J Psychiatry 2000, 157(Suppl 1):81-88.
8. Liu X, Buysse DJ, Gentzler AL, Kiss E, Mayer L, Kapornai K, Vetró A, Kovacs M. Insomnia and hypersomnia associated with depressive phenomenology and comorbidity in childhood depression. Sleep 2007, 30(Suppl 1):83-90.
9. Taylor DJ, Lichstein KL, Durrence HH, Reidel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep 2005, 28(Suppl 11):1457-1464.
10. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol 2008, 76(Suppl 1):84-91. 2823295, 18229986.
11. McGirr A, Renaud J, Seguin M, Alda M, Benkelfat C, Lesage A, Turecki G. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord 2007, 97(Suppl 1-3):203-209. 10.1016/j.jad.2006.06.016, 16854469.
12. Chellappa SL, Araújo JF. Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res 2007, 153(Suppl 2):131-136. 10.1016/j.psychres.2006.05.007, 17658614.
13. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999, 60(Suppl 4):221-225.
14. Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, Papakostas GI. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry 2006, 67(Suppl 11):1754-1759. 10.4088/JCP.v67n1113, 17196056.
15. Worthington J, Fava M, Davidson K, Alpert J, Nierenberg AA, Rosenbaum JF. Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacol Bull 1995, 31(Suppl 2):223-226.
16. Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008, 31(Suppl 4):489-495. 2279754, 18457236.
17. Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 2009, 29(3):222-30. 10.1097/JCP.0b013e3181a390ba, 19440075.
18. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59(Suppl 11):1052-1060. 10.1016/j.biopsych.2006.01.016, 16581036.
19. Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999, 60(Suppl 10):668-676.
20. Ji JL, Liu WJ, Zhang N, Chen ZQ, Zheng AL, Mei QY, Pan JY, Zhao ZX, Tao M, Wang YP, Wei J. Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study. Zhonghua Yi Xue Za Zhi 2007, 87(Suppl 23):1585-1589.
21. Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998, 155(Suppl 8):1119-1121.
22. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia. Am J Psychiatry 1994, 51(Suppl 7):1069-1072.
23. Papakostas GI, Petersen TJ, Burns AM, Fava M. Adjunctive atomoxetine for residual fatigue in major depressive disorder. J Psychiatr Res 2006, 40(Suppl 4):370-373. 10.1016/j.jpsychires.2005.04.013, 15978621.
24. Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 2006, 60(Suppl 12):1350-1355. 10.1016/j.biopsych.2006.06.015, 16934768.
25. Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry 2007, 19(Suppl 3):153-159. 10.1080/10401230701464858, 17729016.
26. Ravindran AV, Kennedy SH, O'Donovan MC, Fallu A, Camacho F, Binder CE. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2008, 69(Suppl 1):87-94. 10.4088/JCP.v69n0112, 18312042.
27. Dombrovski AY, Mulsant BH, Houck PR, Mazumdar S, Lenze E, Andreescu C, Cyranowski J, Reynolds C. Residual symptoms and recurrence during maintenance treatment of late life depression. J Affect Disord 2007, 103:77-82. 10.1016/j.jad.2007.01.020, 2680091, 17321595.
28. Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med 2010, 40:41-50. 10.1017/S0033291709006011, 19460188.
29. McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E. Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am J Psychiatry 2006, 163:1542-1548. 10.1176/appi.ajp.163.9.1542, 16946178.
30. Guy W, . (Ed) ECDEU Assessment Manual for Psychopharmacology, revised. 1976, Rockville, MD, USA: National Institute of Mental Health, (Ed).
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.